Chikungunya Vaccine Trial: Exploring the Results
Manage episode 436702581 series 3517021
内容由ReachMD提供。所有播客内容(包括剧集、图形和播客描述)均由 ReachMD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Host: Matt Birnholz, MD
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
…
continue reading
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
33集单集